<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CINOXACIN</span><br/>(sin-ox'a-sin)<br/><span class="topboxtradename">Cinobac<br/></span><b>Classifications:</b> <span class="classification"> urinary tract antiinfective</span>; <span class="classification">quinolone antibiotic</span><br/><b>Prototype: </b>Ciprofloxacin<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>250 mg, 500 mg capsules</p>
<h1><a name="action">Actions</a></h1>
<p>Synthetic bactericidal agent with properties similar to those of nalidixic acid but with fewer adverse effects. Acts intracellularly
         to inhibit bacterial DNA replication and protein synthesis.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Effective against a wide variety of gram-negative pathogens.</p>
<h1><a name="uses">Uses</a></h1>
<p>Initial and recurrent UTIs in adults caused by susceptible microorganisms.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to cinoxacin or to other quinolones; anuria; dehydration; pregnancy (category B), lactation. Safe use in
         prepubertal children or children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Impaired renal or hepatic function; known CNS disorders, i.e. seizures, tremors, confusion; severe cerebral atherosclerosis.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">UTI</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 1 g/d in 24 divided doses<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give the drug at evenly spaced intervals throughout 24 h so that urinary drug concentration is maintained and therapeutic
            effectiveness enhanced.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> Body as a Whole:</span> Edema, swelling of extremities, arthropathy. <span class="typehead">CNS:</span>
<span class="speceff-common">Headache, dizziness,</span> insomnia, tingling sensations, agitation, anxiety. <span class="typehead">Skin:</span> Urticaria, pruritus, rash.  <span class="typehead">Special Senses:</span>  Tinnitus, photophobia, blurred vision. <span class="typehead">GI:</span>
<span class="speceff-common">Nausea,</span> vomiting, anorexia, constipation, rectal itching, metallic taste, sore gums, abdominal cramps, diarrhea. Other: Cartilage
      erosion. 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>May cause false positive on <span class="alt">opiate screening tests.</span>
</p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Probenecid</b> decreases renal elimination of cinoxacin. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Peak:</span> 23 h. <span class="typehead">Duration:</span> 12 h. <span class="typehead">Distribution:</span> Concentrates in renal and prostatic tissues; crosses placenta; distribution into breast milk unknown. <span class="typehead">Elimination:</span> 97% excreted in urine within 24 h. <span class="typehead">Half-Life:</span> 1.5 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Lab tests: Culture and sensitivity tests should be performed before start of therapy and during therapy if response is not
            satisfactory.
         </li>
<li>Monitor ambulation since dizziness is a possible side effect, especially with the older adult and debilitated, may be warranted.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Take drug for the full course of therapy as prescribed.</li>
<li>Report to physician if symptoms do not improve within a few days or if they become worse.</li>
<li>Avoid driving and other potentially hazardous tasks until reaction to drug is known.</li>
<li>Report to physician if tinnitus develops.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>